RAPT Therapeutics stock plunges as FDA halts two clinical tr

RAPT Therapeutics shares dropped more than 60% premarket on Tuesday after the company said regulators have hit pause on two clinical trials of its...

Related Keywords

Brian Wong , Rapt Therapeutics Inc , Drug Administration , Goldman Sachs , Article Normal , Biotechnology Services , Pharmaceuticals , Computers Consumer Electronics , Software , Applications Software , Healthcare Life Sciences , Biopharmaceuticals , Computing , Technology , Regulation Government Policy , New Products Services , Research Development , Corporate Industrial News , Products Services , New Product Service Testing , Asthma , Political General News , Respiratory Tract Diseases , Health , Medical Conditions , Content Types , Factiva Filters , C Amp Ampe Industry News Filter , Strapt , Regulation , Government Policy , New Products , Services , Research , Development , Corporate , Industrial News , Products , New Product , Service Testing , Political , General News , Computers , Consumer Electronics , Healthcare , Life Sciences ,